Simcere Pharmaceutical Group (SCR.N)
SCR.N on New York Stock Exchange
9.32USD
1:36am IST
9.32USD
1:36am IST
Price Change (% chg)
$0.03 (+0.32%)
$0.03 (+0.32%)
Prev Close
$9.29
$9.29
Open
$9.20
$9.20
Day's High
$9.35
$9.35
Day's Low
$9.20
$9.20
Volume
2,580
2,580
Avg. Vol
11,000
11,000
52-wk High
$9.58
$9.58
52-wk Low
$7.30
$7.30
About
Simcere Pharmaceutical Group is a holding company. The Company principally engaged in the research, development, manufacture and distribution of pharmaceutical and vaccine products in the People’s Republic of China. As of December 31, 2011, it manufactured and sold 47 pharmaceutical products and is the distributor of two... (more)
Overall
| Beta: | 0.80 |
| Market Cap (Mil.): | $476.19 |
| Shares Outstanding (Mil.): | 51.28 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| SCR.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 25.70 | 34.14 | 34.28 |
| EPS (TTM): | 0.36 | -- | -- |
| ROI: | 4.19 | 19.49 | 18.85 |
| ROE: | 5.92 | 20.26 | 19.72 |
UPDATE 2-China's Simcere Pharma receives go-private offer from chairman
March 11 - Simcere Pharmaceutical Group received a buyout offer from a consortium led by founder-chairman Jinsheng Ren, the latest in a series of China-based companies going private to avoid regulatory scrutiny in the United States.
China's Simcere Pharma gets buyout offer from chairman
March 11 - China-based Simcere Pharmaceutical Group received a buyout offer from a consortium led by Chairman Jinsheng Ren for $9.56 per American depositary share (ADS), valuing the company at about $500 million.
Competitors
| Price | Change | |
|---|---|---|
| North China Pharmaceutical Co., Ltd. (600812.SS) | ¥5.88 | +0.03 |
| Johnson & Johnson (JNJ.N) | $86.82 | -0.39 |
| Novartis AG (NOVN.VX) | CHF71.25 | -0.20 |
| China Biopharma Inc. (CHBO.PK) | $0.00 | -0.00 |
| AIDA Pharmaceuticals, Inc. (AIDA.PK) | $0.03 | -0.01 |
| Sanofi SA (SASY.PA) | €84.51 | -0.30 |
| Bayer AG (BAYGn.DE) | €84.46 | +0.55 |
| Bayer AG (BAYE.F) | -- | -- |
| Abbott Laboratories (ABT.N) | $37.76 | +0.28 |
| Roche Holding Ltd. (ROG.VX) | CHF253.10 | +2.40 |

Estimates